🔗 Share this article

The top legal official in Texas Ken Paxton is taking legal action against the manufacturers of Tylenol, asserting the companies withheld alleged dangers that the drug created to pediatric cognitive development.

The court filing follows four weeks after Former President Trump promoted an unsubstantiated connection between using Tylenol - referred to as paracetamol - while pregnant and autism spectrum disorder in offspring.

Paxton is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication suggested for women during pregnancy, and Kenvue, which currently produces it.

In a declaration, he claimed they "misled consumers by profiting off of suffering and marketing drugs regardless of the dangers."

The manufacturer states there is no credible evidence tying Tylenol to autism.

"These companies misled for generations, knowingly endangering countless individuals to line their pockets," Paxton, from the Republican party, said.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the security of acetaminophen and the likely effects that could have on the welfare of American women and children."

On its official site, Kenvue also mentioned it had "continuously evaluated the applicable studies and there is lacking reliable evidence that shows a established connection between taking acetaminophen and autism."

Groups acting on behalf of doctors and medical practitioners share this view.

The American College of Obstetricians and Gynecologists has declared paracetamol - the primary component in Tylenol - is among limited choices for women during pregnancy to manage discomfort and fever, which can present significant medical dangers if not addressed.

"In more than two decades of research on the use of acetaminophen in gestation, no reliable research has definitively established that the usage of acetaminophen in any stage of gestation results in neurodevelopmental disorders in children," the association commented.

This legal action mentions current declarations from the Trump administration in arguing the drug is reportedly hazardous.

Last month, the former president generated worry from medical authorities when he told expectant mothers to "fight like hell" not to use Tylenol when ill.

Federal regulators then released a statement that doctors should think about restricting the consumption of Tylenol, while also mentioning that "a direct connection" between the medication and autism spectrum disorder in children has not been proven.

Health Secretary RFK Jr, who supervises the FDA, had vowed in spring to initiate "a massive testing and research effort" that would identify the source of autism in a limited time.

But authorities cautioned that identifying a unique factor of autism spectrum disorder - considered by experts to be the result of a intricate combination of genetic and external influences - would prove challenging.

Autism spectrum disorder is a type of permanent neurological difference and condition that impacts how people perceive and interact with the world, and is identified using doctors' observations.

In his court filing, Paxton - who supports Trump who is seeking US Senate - alleges the manufacturer and J&J "deliberately disregarded and attempted to silence the evidence" around paracetamol and autism spectrum disorder.

The lawsuit aims to force the corporations "eliminate any commercial messaging" that states acetaminophen is secure for women during pregnancy.

The court case mirrors the concerns of a group of guardians of children with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in recently.

Judicial authorities dismissed the case, saying investigations from the plaintiffs' authorities was lacking definitive proof.